Pfizer's next-gen pneumonia shot beats Prevnar 20; Relay targets $175M

Pfizer’s experimental 25-valent pneumococcal shot beats Prevnar 20; Relay Therapeutics charts $175M offering; Lilly to pay up to $202 million for non-viral DNA delivery specialist

Raccontata daendpoints.news